- USANA Health Sciences press release (NYSE:USNA): Q1 GAAP EPS of $0.95 beats by $0.18.
- Revenue of $248M (-9.1% Y/Y) beats by $7.8M.
- Fiscal 2023 net sales and diluted EPS guidance updated to $875 to $950 million vs $935.3M consensus and $2.40 to $3.30 vs. $2.85 consensus, respectively, from $850 million to $950 million and $2.35 to $3.30.
USANA Health Sciences GAAP EPS of $0.95 beats by $0.18, revenue of $248M beats by $7.8M
Recommended For You
More Trending News
About USNA Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| USNA | - | - |
| USANA Health Sciences, Inc. | ||